{"id":1172,"date":"2024-08-13T12:00:29","date_gmt":"2024-08-13T12:00:29","guid":{"rendered":"https:\/\/mint-team.fr\/?page_id=1172"},"modified":"2024-08-13T12:21:03","modified_gmt":"2024-08-13T12:21:03","slug":"julien-lancelot","status":"publish","type":"page","link":"https:\/\/mint-team.fr\/index.php\/julien-lancelot\/","title":{"rendered":"Julien Lancelot CV"},"content":{"rendered":"
\n
\"\"<\/figure><\/div>\n\n\n

Date of birth: 20\/09\/1987 Nationality: French<\/p>\n\n\n\n

ResearchGate: https:\/\/www.researchgate.net\/profile\/Julien-Lancelot<\/a><\/p>\n\n\n\n

Linkedin: https:\/\/fr.linkedin.com\/in\/julien-lancelot-293aa492<\/a> <\/p>\n\n\n\n

ORCID: https:\/\/orcid.org\/0000-0002-1648-819X<\/a><\/p>\n\n\n\n

As part of the Mint team, my work is currently focused on characterising the biological activity of K1K1 in vitro<\/em> and in vivo<\/em> and studying its role as a potential drug in various pathologies. I also have strong expertise in the biology of the schistosome, a flatworm responsible for bilharzia (the world’s second-largest parasitic endemic), and in the in vitro<\/em> and in vivo<\/em> screening of new molecules directed against the schistosome.<\/p>\n\n\n\n

EDUCATION<\/strong><\/p>\n\n\n\n

\n
\n

2010-2013<\/p>\n<\/div>\n\n\n\n

\n

PhD Student in Biology and Health Science. Institut Pasteur Lille (IPL) \u2013 Lille (France). Schistosoma mansoni<\/em> sirtuin characterization: potential therapeutic targets, supervised by Dr. Raymond Pierce.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2009<\/p>\n<\/div>\n\n\n\n

\n

Master Degree in Drug Design. Institut Pasteur Lille (IPL) \u2013 Lille (France). Schistosoma mansoni<\/em> sirtuin characterization, supervised by Dr. Raymond Pierce.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2008-2009<\/p>\n<\/div>\n\n\n\n

\n

Engineering degree in Drug Design. Institut de Recherche pour le Cancer de Lille (IRCL) \u2013 Lille (France). <\/p>\n\n\n\n

Optimisation of a capillary electrophoresis analytical method for the plasma dosage of an anticancer drug, supervised by Dr. Am\u00e9lie LANSIAUX and Dr. Jean Fran\u00e7ois GOOSSENS.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2007-2008<\/p>\n<\/div>\n\n\n\n

\n

DU in Techniques for Elaboration and Analyses of Biomolecules. Institut de Recherche pour le Cancer de Lille (IRCL) \u2013 Lille (France). <\/p>\n\n\n\n

Optimisation of a capillary electrophoresis analytical method for the plasma dosage of an anticancer drug, supervised by Dr. Am\u00e9lie LANSIAUX and Dr. Jean Fran\u00e7ois GOOSSENS.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2005-2007<\/p>\n<\/div>\n\n\n\n

\n

Technician degree in Organic Chemistry and Analytical Chemistry. Genfit S-A \u2013 Lille (France). <\/p>\n\n\n\n

Development of a universal HPLC analytical method for studying the purity of molecules synthesised in the laboratory, supervised by Dr. Marie LEBAS.<\/p>\n<\/div>\n<\/div>\n\n\n\n

WORKING EXPERIENCE<\/strong><\/p>\n\n\n\n

\n
\n

2023-2024<\/p>\n<\/div>\n\n\n\n

\n

Postdoctoral researcher. Institut Pasteur Lille (IPL) \u2013 Lille (France).<\/p>\n\n\n\n

Evaluation of the biological activity of K1K1, a c-met agonist: potential therapeutic activity, supervised by Dr. J\u00e9r\u00f4me Vicogne.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2022<\/p>\n<\/div>\n\n\n\n

\n

Postdoctoral researcher. Institut Pasteur Lille (IPL) \u2013 Lille (France)<\/p>\n\n\n\n

Study of the in vitro<\/em> and in vivo<\/em> activity of anti-schistosome compounds and cytotoxicity evaluation of promising compounds in human cell lines, supervised by Dr. Oleg Melnyk.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2020-2021<\/p>\n<\/div>\n\n\n\n

\n

Postdoctoral researcher. Institut Pasteur Lille (IPL) \u2013 Lille (France)<\/p>\n\n\n\n

Study of the in vitro<\/em> and in vivo<\/em> activity of a compound currently in clinical trials for the treatment of neurodegenerative diseases, with a view to repositioning it in the treatment of schistosomiasis, supervised by Dr. Oleg Melnyk.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2018-2019<\/p>\n<\/div>\n\n\n\n

\n

Postdoctoral researcher. Institut Pasteur Lille (IPL) \u2013 Lille (France)<\/p>\n\n\n\n

Phenotypic screening of Histone Modifying Enzyme (HME) inhibitors on Schistosoma mansoni<\/em>. Optimisation of miceinfestation by S. mansoni<\/em>. Study of the viability of parasites under hypoxic conditions, supervised by Dr. Raymond Pierce.<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

2014-2017<\/p>\n<\/div>\n\n\n\n

\n

Postdoctoral researcher. Institut Pasteur Lille (IPL) \u2013 Lille (France)<\/p>\n\n\n\n

Responsible for phenotypic screening on S.mansoni<\/em> as part of the European A-ParaDDiSE project (~600 molecules studied). Study of the involvement of Sirtuins in Schistosome biology, supervised by Dr. Raymond Pierce.<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Date of birth: 20\/09\/1987 Nationality: French ResearchGate: https:\/\/www.researchgate.net\/profile\/Julien-Lancelot Linkedin: https:\/\/fr.linkedin.com\/in\/julien-lancelot-293aa492 ORCID: https:\/\/orcid.org\/0000-0002-1648-819X As part of the Mint team, my work is currently focused on characterising the biological activity of K1K1 in vitro and in vivo and studying its role as a potential drug in various pathologies. I also have strong expertise in the biology of… Read More »Julien Lancelot CV<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"_ti_tpc_template_sync":false,"_ti_tpc_template_id":"","footnotes":""},"_links":{"self":[{"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/pages\/1172"}],"collection":[{"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/comments?post=1172"}],"version-history":[{"count":2,"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/pages\/1172\/revisions"}],"predecessor-version":[{"id":1241,"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/pages\/1172\/revisions\/1241"}],"wp:attachment":[{"href":"https:\/\/mint-team.fr\/index.php\/wp-json\/wp\/v2\/media?parent=1172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}